Advice

following an abbreviated submission:

insulin lispro (Humalog® KwikPen) is accepted for use within NHS Scotland for the treatment of adults and children with diabetes mellitus who require insulin for maintenance of normal glucose homeostasis, and for the initial stabilisation of diabetes mellitus.

It may be used in patients for whom treatment with this short-acting insulin analogue is appropriate.

Download detailed advice29KB (PDF)

Download

Medicine details

Medicine name:
insulin lispro (Humalog KwikPen)
SMC ID:
508/08
Indication:
for adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Pharmaceutical company
MSD
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Accepted
Date advice published
13 October 2008